17-dihydroexemestane
โ Previous: 13ฮฒ-ethyl-17ฮฒ-hydroxygon-4-en-3-one | ๐ All Substances | ๐ Complete Table | Next: 17alpha-methyl-3alpha,17beta-dihydroxy-5alpha-androstane โ
OPSS Properties
| Classifications | 6000 |
| Reason | WADA S4: Hormone and Metabolic Modulators; Unapproved drug |
| Also Known As |
|
| Prohibited Because | WADA S4: Hormone and Metabolic Modulators (WADA Prohibited List S4: Hormone and Metabolic Modulators) Unapproved Drug |
| Added to Database | December 30, 2025 |
| Source Last Updated | February 6, 2025 |
| GUID | a5ea79cb-8a9a-4ddf-b950-2bed156bc064 |
References
External Resources
- FDA UNII Search
- GSRS Full Record
- NCATS Inxight Drugs
- CAS Common Chemistry
- PubChem
- EPA CompTox Dashboard
UNII: U35ZNO9DJH ยท CAS: 140461-66-1
PubChem Properties
Chemical Structure
Interactive 3D Structure
| Molecular Formula | C20H26O2 |
| Molecular Weight | 298.4 g/mol |
| IUPAC Name | (8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-6-methylidene-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-3-one |
| InChIKey | NFDPYPMRHKQTDM-NHWXPXPKSA-N |
๐ Complete Table | ๐ All Substances
Substance 23 of 880